The purpose of this procurement procedure is to purchase capacity to support the Agency in
the preparation of high-quality scientific services and overall to increase the Agency’s
timeliness, anticipatory and responsive capacity. The Agency requires access to supporting
specialised expertise in the design, conduct, and reporting of different types of scientific
work. Outputs may include reports, digital dashboards, AI based tools, methodological and
reporting guidelines, training materials, workshops, databases, collection of literature, etc.
The present procurement procedure is aimed at supporting the Agency to rapidly mobilise
external expertise in a flexible and efficient manner, ensuring responsiveness to evolving
scientific priorities and emerging evidence needs.
The activities resulting from this procedure are expected to support the EUDA in monitoring
drug markets, use of substances and their consequences. They will also help identify the
evidence needed to inform responses in terms of establishing trends, examining emerging
threats and tracking developments over time and between settings.
Ultimately, this is expected to strengthen the preparedness of the Agency, and of the EU as a
whole, to respond to drug-related harms.
| Ilmoitusnumero | 689624-2026 |
|---|---|
| Ilmoitusta kuvaavat CPV-Koodit | Tutkimus- ja kehityspalvelut ja niihin liittyvät konsulttipalvelut (73000000) |
| EUVL S | 194/2026 |
| Ilmoitustyyppi | Hankintailmoitus (tarjouspyyntö) |
| Aluekoodi | |
| Osoitetiedot |
European Union Drugs Agency Lisbon infoprocurement@euda.europa.eu https://ted.europa.eu/en/notice/-/detail/689624-2026 |
| Osoite, johon tarjoukset tai osallistumispyynnöt on lähetettävä | |
| Liitteet | |
| Lähde | TED |